Free Trial
NASDAQ:MEDS

TRxADE HEALTH (MEDS) Stock Price, News & Analysis

TRxADE HEALTH logo
$1.03 +0.01 (+0.97%)
As of 08/22/2025

About TRxADE HEALTH Stock (NASDAQ:MEDS)

Key Stats

Today's Range
$0.89
$1.05
50-Day Range
$0.90
$2.39
52-Week Range
$3.69
$44.56
Volume
445,972 shs
Average Volume
207,831 shs
Market Capitalization
$1.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MEDS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TRxADE HEALTH and its competitors with MarketBeat's FREE daily newsletter.

MEDS Stock News Headlines

TRxADE HEALTH (NASDAQ:MEDS) Shares Down 2.5% - Here's Why
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.tc pixel
TRxADE Health (NASDAQ: MEDS)
Scienture Holdings, Inc. (SCNX)
See More Headlines

MEDS Stock Analysis - Frequently Asked Questions

TRxADE HEALTH's stock was trading at $6.20 at the start of the year. Since then, MEDS shares have decreased by 83.4% and is now trading at $1.03.

TRxADE HEALTH, Inc. (NASDAQ:MEDS) released its quarterly earnings results on Sunday, October, 24th. The company reported ($2.40) EPS for the quarter, missing the consensus estimate of ($1.95) by $0.45. The business earned $2.55 million during the quarter, compared to analysts' expectations of $1.94 million. TRxADE HEALTH had a negative net margin of 149.81% and a negative trailing twelve-month return on equity of 196.79%.

Shares of TRxADE HEALTH reverse split on Thursday, June 22nd 2023.The 1-15 reverse split was announced on Thursday, June 22nd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Shares of MEDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that TRxADE HEALTH investors own include NVIDIA (NVDA), Communications Systems (JCS), Biora Therapeutics (BIOR), Paratek Pharmaceuticals (PRTK), Citius Pharmaceuticals (CTXR), Meta Platforms (META) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
10/24/2021
Today
8/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Drugs, proprietaries, & sundries
Sub-Industry
Wholesale
Current Symbol
NASDAQ:MEDS
CIK
1382574
Employees
50
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$17.84 million
Net Margins
-149.81%
Pretax Margin
-250.53%
Return on Equity
-196.79%
Return on Assets
-112.21%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.18
Quick Ratio
4.18

Sales & Book Value

Annual Sales
$7.45 million
Price / Sales
0.19
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.45 per share
Price / Book
2.29

Miscellaneous

Outstanding Shares
1,406,000
Free Float
725,000
Market Cap
$1.45 million
Optionable
Not Optionable
Beta
2.32

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:MEDS) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners